Press Releases

  • October 1, 2018

    PROCEPT BioRobotics’ Aquablation Therapy Expands Global Market Access with NICE Guidance and NTAP Incremental Payment

    Enhanced Guidance and Incremental Reimbursement Will Strengthen Continued Global Growth of Aquablation Therapy for the Treatment for Benign Prostatic Hyperplasia (BPH)  REDWOOD SHORES, Calif. – October 1, 2018 ... Read more

  • June 18, 2018

    PROCEPT BioRobotics Named 2018 MedTech Breakthrough Award Winner

    PROCEPT BioRobotics’ AQUABEAM System Recognized with “Best Healthcare Robotics Solution” Award REDWOOD SHORES, Calif. –June 19, 2018 – PROCEPT BioRobotics today announced that it has been selected as the ... Read more

  • May 21, 2018

    PROCEPT BioRobotics’ Aquablation Meets Primary Endpoints in WATER II Study of 80 to 150 Milliliter Prostates

    Procedure Confirmed as a Safe, Effective, Heat-Free Treatment of BPH in a Broad Range of Prostates REDWOOD SHORES, Calif. – May 21, 2018 – PROCEPT BioRobotics, a Silicon Valley robotics company developing intell... Read more

  • December 21, 2017

    FDA Grants De Novo Request for PROCEPT BioRobotics AquaBeam System

    System’s Aquablation® Technology Offers Heat-free Robotic Alternative for the Minimally Invasive Treatment of Benign Prostatic Hyperplasia (BPH) REDWOOD SHORES, Calif. – Dec. 21, 2017 – PROCEPT BioRobotics , ... Read more

  • October 31, 2017

    PROCEPT BioRobotics Announces Milestones in Europe: First Commercial Aquablation Cases Completed in Germany and Initiation of FRANCAIS WATER Clinical Trial

    REDWOOD SHORES, Calif. – October 31, 2017 – PROCEPT BioRobotics, a Silicon Valley surgical robotics company developing novel and disruptive technologies to treat prostate disease, announced that the first commer... Read more

  • September 27, 2017

    PROCEPT BioRobotics Announces First Patients Treated in WATER II Pivotal Clinical Trial

    PROCEPT BioRobotics Announces First Patients Treated in WATER II Pivotal Clinical Trial Study Will Evaluate the Safety and Efficacy of Aquablation in Large Prostates for Patients with Lower Urinary Tract Symptoms Du... Read more

  • October 27, 2016

    PROCEPT BioRobotics Announces Educational Support for 2017 American Urological Association Visiting Scholar Program

    A collaborative and exciting program that fosters the alliance between the AUA, BAUS and DGU, assisting in identifying future leaders within those organizations REDWOOD SHORES, California, October 27, 2016 – PROCE... Read more

  • December 15, 2015

    PROCEPT BioRobotics Announces First Patients Treated in Global IDE Clinical Trial for BPH

    WATER Study to evaluate the effectiveness and safety of Aquablation in the targeted and heat-free resection of prostate tissue REDWOOD SHORES, California, December 3, 2015 – PROCEPT BioRobotics, a medical device c... Read more

  • July 7, 2015

    PROCEPT BioRobotics Announces Closing of $42 Million in New Funding

    Financing to Support Phase III Clinical Trial and International Commercialization of AQUABEAM® for the Treatment of Benign Prostatic Hyperplasia REDWOOD SHORES, California, July 7, 2015 – PROCEPT BioRobotics, a p... Read more

  • May 15, 2015

    PROCEPT BioRobotics Presents Phase II Data on Treatment of Benign Prostatic Hyperplasia with Aquablation using the AquaBeam®

    Data demonstrate the performance and the preliminary safety and effectiveness of a novel image-guided robotic surgical system that uses high velocity saline to efficiently resect prostate tissue REDWOOD SHORES, Cali... Read more

  • Media Contact

    Get in Touch

    Nobles Global Communications
    +1 (818) 618 5634
    diana@noblesgc.com

    Media Contact

    Get in Touch

    Nobles Global Communications
    +1 (818) 618 5634
    diana@noblesgc.com